Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418313 · ClinicalTrials.gov registry record
Non-Invasive Imaging of Atherosclerosis
A clinical trial of Atherosclerosis, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 886
- Enrollment target
- 1
- Study location
NCT01418313 is a study of Atherosclerosis that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 886 participants, below the 1,053-participant average among 69 other Atherosclerosis trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01418313, a study of Atherosclerosis, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 886 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and validate novel magnetic resonance imaging (MRI), dynamic contrast enhanced (DCE)-MRI and positron emission tomography (PET)/MR techniques for the detection and risk stratification of patients with atherosclerosis.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 886 participants |
| Start Date | 2011-09 |
| Est. Completion | 2020-03-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01418313
The ClinicalTrials.gov registry entry for NCT01418313 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 886 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,053-participant average among 69 other Atherosclerosis trials with a reported enrollment target (16% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT01418313 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01418313 about?
NCT01418313 is a clinical study titled "Non-Invasive Imaging of Atherosclerosis". The purpose of this study is to develop and validate novel magnetic resonance imaging (MRI), dynamic contrast enhanced (DCE)-MRI and positron emission tomography (PET)/MR techniques for the detection and risk stratification of patients with atherosclerosis.
What is the current status of trial NCT01418313?
This trial is currently completed. The enrollment target is 886 participants. The study started on 2011-09. Estimated completion is 2020-03-09.
What conditions does trial NCT01418313 study?
This clinical trial studies the following conditions: Atherosclerosis.
Who is sponsoring clinical trial NCT01418313?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01418313 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RECRUITING · Phase 4
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
-
Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.